New York Braun IVC Filters Attorneys
Braun IVC Lawsuits
The VenaTech Convertible and VenaTech LP are both manufactured by global medical device company Braun whose US headquarters is located in Bethlehem, Pennsylvania. The company boasts that it is the 13th largest medical device manufacturer in the world. According to the company’s website, more than 200,000 Vena Tech LP filters have been implanted worldwide.
The Vena Tech Convertible and Vena Tech LP IVC filter are designed to remain implanted permanently. The Vena Tech Convertible, however, is designed to allow for removal once a pulmonary embolism has passed. Hence, the name “convertible” which is not true regarding the Vena Tech LP.
Helping Clients Nationwide
Our New York defective medical device lawyers are now accepting cases from people harmed by the Braun IVC Filters. Call (888) 260-0473 today!
IVC filters are commonly used to treat patients who are at risk for pulmonary embolism (a blood clot in the lungs) when treatment with blood thinners cannot be used or is ineffective. While some IVC filters are left in place permanently, the FDA issued a safety communication in 2014External Link Disclaimer based on reports of adverse events associated with IVC filters and recommended that implanting physicians consider removing the filter as soon as blood clots are no longer a risk for the patient.
Complications with IVC Filters
However, permanent implantation of these IVC filters have caused serious medical complications due to the risk of fracturing and migration to other areas of the body. The manufacturer claims these products are safe, but a multitude of IVC filter complications and injuries have proven otherwise. Both filters have shown a tendency to fracture and migrate from the vena cava, sometimes into the heart. Additional complications include organ perforation, filter fracture, punctured veins and more.
IVC filters (also known as vena cava filters or blood clot filters) are small, cage-like devices that are inserted into the inferior vena cava — a large vein that carries deoxygenated (blue) blood from the lower body to the heart — in patients who are unable to take anticoagulants in order to prevent blood clots from reaching the lungs. The devices were first introduced in 1979, and have been increasingly used ever since. By 2012, nearly 260,000 IVC filters were implanted in patients across the U.S.
In 2010, the FDA issued a warning concerning permanent implantation of these IVC filters. The FDA recommended that the filters be removed as soon as the blood clot risk subsides, typically between the 29th and 54th day after implantation. Unfortunately, this warning came too late for many IVC filter recipients.
Further complicating the situation was findings released by JAMA in April 2013 that noted the high degree of difficulty in removing these filters once implanted due to the filter becoming embedded making retrieval nearly impossible. Doctors made 13 unsuccessful removal attempts, 11 of which occurred in patients who had their filters implanted for over 85 days. Of the 13 unsuccessful removal attempts:
- 8 patients were unable to have their IVC filters removed because they were embedded;
- 3 patients’ filters had punctured a blood vessel;
- 2 patients’ devices had migrated from the implant site, and
- 1 patient had a blood clot inside the vena cava filter
The attorneys at Rheingold, Giuffra, Ruffo & Plotkin are accepting cases involving these Braun IVC filters and have decades of experience working with defective medical devices including IVC filters.
If you have had a Braun IVC filter installed, call (888) 260-0473 to reach a member of our firm and find out if you have grounds for legal action.